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Helicobacter pylori genomes typically contain 8 or 9 genes that code for secreted and highly disul-
ﬁde-bridged proteins designated Helicobacter cysteine-rich proteins (Hcp). Here we show that HcpA
(hp0211) but not HcpC (hp1098) triggers the differentiation of human myeloid Thp1 monocytes into
macrophages. Small amounts of HcpA cause the transition of round-shaped monocytes into cells
with star-like morphologies, adherence to the culture dish surface, phagocytosis of opsonized ﬂuo-
rescent microspheres, and expression of the surface marker protein CD11b, all of which are indica-
tive of a macrophage-like phenotype. We conclude that HcpA acts as a bacterial immune modulator
similar to a eukaryotic cytokine.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction The genome sequences of six H. pylori strains reveal a family ofThe gram-negative e-proteobacterium Helicobacter pylori
chronically infects the gastric mucosa of humans and certain other
vertebrates, a niche that is hostile to all other microbes. H. pylori
infections tend to persist for life if not treated, implying effective
adaptation to this harsh ecological niche [1]. The interactions be-
tween H. pylori and the host innate immune system seem to be
of particular importance in the persistence of infection and devel-
opment of pathological states such as peptic ulcer disease and gas-
tric cancer [2–6].chemical Societies. Published by E
A, nitrilotriacetic acid; FACS,
m albumin; PBS, phosphate8 or 9 conserved hypothetical proteins with a high content of disul-
ﬁde bridges [7–10] that accordingly were designated Helicobacter
cysteine-rich proteins (Hcp) [11,12]. HcpA and most other family
members carry N-terminal leader sequences for periplasmic
expression and HcpA was found to be secreted into the superna-
tant of H. pylori cultures [11], which would allow it to directly con-
tact eukaryotic host cells. Several Hcps were detected based on
high antibody titres against them in H. pylori infected patients
((HcpA and HcpC studied here, and HcpE), showing that these pro-
teins, in particular, are well expressed in vivo [13].
The crystal structures of HcpC and HcpB revealedmodular archi-
tectures consisting of four and seven Sel1-like repeats (SLR), respec-
tively. The SLR motif is 36–44 amino acids long and folds into pairs
of anti-parallel a-helices. The structural similarity between SLR
proteins and tetratricopeptide repeat (TPR) proteins suggests that
Hcps might act as protein–protein interaction modules in signallsevier B.V. All rights reserved.
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supported by the observation that recombinant HcpA elicits high
titres of pro-inﬂammatory cytokines, such as IFN-c, TNF-a, IL-6,
IL-10, and IL-12, in a cellular assay of naïve mouse splenocytes [15].
Additional evidence that Hcps might modulate interactions
between H. pylori and its host comes from an analysis of phase var-
iable H. pylori genes. Phase variation by frameshift mutations in
repetitive DNA sequences is a common mechanism used by path-
ogenic bacteria to generate intra-strain diversity and to evade spe-
ciﬁc adaptive immune system responses. The hcpA and hcpB genes
undergo phase variation, suggesting that their gene products are
important for niche adaptation [16]. A recent statistical analysis
of Hcp sequence data supports this inference. Several Hcps show
signatures of selection for amino acid change, implying adaptive
evolution in different human populations [17].
The differentiation of monocytes into macrophages is a crucial
step in the early immune response, and the human monocytic leu-
kemia cell lines Thp1 and U937 have been frequently used as
in vitro models to investigate this process. Several compounds
such as phorbol 12-myristate 13-acetate (PMA), 1,25-dihydroxyvi-
tamin D3, retinoic acid, or eukaryotic cytokines have been used to
trigger this differentiation process, which can be monitored by
changes in morphology, adherence, phagocytosis, the expression
of surface markers or the release of prostaglandine E and TNF-a
[18,19]. The magnitude of the signal obtained depends on the stim-
ulating agent; PMA has one of the strongest effects.
Here we investigated the effects of recombinant HcpA and HcpC
on Thp1 and U937 cell-lines. We found that small amounts of HcpA
stimulate adherence of Thp1 cells to the culture dish surface, foster
phagocytosis of ﬂuorescent microspheres, trigger a transition of
round-shaped monocytes into cells with star-like morphologies,
and stimulate expression of surface markers that are indicative
for macrophage-like phenotypes, such as CD11b. We conclude that
HcpA shows cytokine-like properties and – at least transiently –
provokes a human monocyte to macrophage differentiation.2. Material and methods
2.1. Expression of recombinant HcpA and HcpC
We expressed HcpA and -C as soluble maltose binding protein
(Mbp)-fusion proteins in the periplasm of E. coli, thereby avoiding
the need to refold them from inclusion bodies that complicated pre-
vious studies [12,20]. HcpA and -Cwere puriﬁed by exactly the same
strategies, making use of two afﬁnity chromatography steps on
amylose- and Ni-nitrilotriacetic acid (NTA)-agarose resins (Supple-
mentary experimental procedures). After deletion of the bulky N-
terminal Mbp-tags, cleaved HcpA-His6 and HcpC-His6 where con-
centrated by ultra-ﬁltration and ﬁnally ﬁltered through 0.1 lm
spin-ﬁlters to prevent bacterial contaminations. Recombinant HcpA
and -C were >95% pure as judged by SDS–PAGE and reversed-phase
HPLC analysis (Supplementary Fig. 1). The ﬂow-through of the ﬁnal
ultra-ﬁltration step was ﬁltered and kept as a negative control for
subsequent cell stimulation experiments. Since Thp1 andU937 cells
are sensitive to bacterial endotoxins, such as lipopolysaccarides
(LPS), the possibility of contamination of recombinant Hcp prepara-
tionswith endotoxinswas investigated using the Limulus amebocyte
lysate test. Endotoxin concentrations were below 1.25 endotoxin
units (EU)/ml in ﬂow-through buffers of HcpA and -C preparations,
which corresponds to less than 0.3 ± 0.1 EU/mg HcpA.
2.2. Stimulation of cells and adherence
Thp1 and U937 cells were maintained under standard condi-
tions. To estimate cell adherence cultures were cooled to 4 Capproximately 5–24 h after stimulation. Loosely attached cells
were re-suspended in the medium and the supernatant was with-
drawn. Adherent cells were washed with phosphate buffer saline
(PBS) and the washing solution was added to the culture superna-
tant. Adherent cells were detached with 150 lL trypsin/EDTA solu-
tion (Sigma) and the culture dish was rinsed with 850 lL PBS,
which was later combined with the suspension of detached cells.
After gentle mixing 25–300 lL of cell suspension was diluted with
10 mL isotonic buffer and cells were counted in a CASY cell counter
(Schärfe System). For statistical analysis, Student’s t-test function,
assuming unequal variances, was applied.
2.3. Phagocytosis
Thp1 cells were stimulated with varying concentrations of
HcpA, HcpC or PMA and allowed to differentiate for 21 h. Opso-
nized polystyrene particles were prepared by incubating 3 lL
green ﬂuorescent microspheres (2.5% suspension of 1 lm beads,
Sigma) in 300 lL 10% foetal calf serum for 1 h at 37 C. Opsonized
microspheres were added to Thp1 cell cultures (approximately
0.6  106 cells/ml) at a ratio of 10 microspheres per cell. Cultures
were maintained at 37 C for 1 h and cooled to 4 C to harvest
the cells by trypsinisation. After washing the mixture of suspended
and adherent cells once with 12 mL ﬂuorescence-activated cell
sorting (FACS) buffer (0.1% bovine serum albumin (BSA) in PBS),
cells were re-suspended in 300 lL FACS buffer and analysed by
ﬂow-cytometry (BD FACScanto II).
2.4. Expression of surface markers
The expression of the b2 integrin CD11b was estimated by ﬂow-
cytometry. Thp1 cell cultures (2 mL) in either 3.5 cm culture dishes
or 12-well plates were stimulated with varying concentrations of
HcpA, HcpC or PMA and maintained over night. Cells were har-
vested by trypsinisation and washed once with 10 mL FACS buffer.
After adding 1 lL ﬂuorescein isothiocyanate (FITC) labelled rat
anti-CD11b antibody (BD Pharmingen) to 100 lL cells in FACS buf-
fer the mixture was kept on ice for 1 h. Cells were washed once
with 10 mL FACS buffer and analysed by ﬂow-cytometry.
2.5. In vivo analysis
To analyse the contribution of HcpA in vivo we compared the
colonization behaviour of H. pylori strain X47 with an isogenic hcpA
knockout mutant. This mutant was generated by replacing the
hcpA gene with an rpsL,erm (streptomycin susceptibility, erythro-
mycin resistance) cassette in a two-step PCR protocol as described
[21]. The X47 DhcpA transformants were then tested in C57BL/6
mice (Supplementary experimental procedures).
3. Results
3.1. Morphology
We investigated the effects of recombinant HcpA and -C on the
morphology of human Thp1monocytes. Under normal culture con-
ditions Thp1 cells had round morphologies, which was signiﬁ-
cantly affected by recombinant HcpA addition. HcpA
concentrations between 10 nM and 100 nM stimulated the transi-
tion from round to star-like morphologies (Fig. 1a and b). To quan-
tify this effect cells with star-like morphologies were counted after
stimulation with varying concentrations of HcpA, HcpC, ﬂow-
through buffer or PMA. A P-value of 1.9  105 for HcpA at
120 nM indicates that HcpA had an equally signiﬁcant effect on
the morphology of Thp1 cells compared to PMA (Fig. 1c). In con-
trast, no such effect was seen for the stimulation of U937 cells with
Fig. 1. Phase contrast light microscopy images of Thp1 cells. (a) Cells after adding 460 nM HcpA. An arrow in the magniﬁed insert indicates ﬁlopodia. (b) Cells after adding
ﬂow-through buffer at an equal dilution. (c) Given are the numbers of cells with star-like morphologies after treatment with 120 nM HcpA, HcpC, PMA, or ﬂow-through
buffer. P-values for the comparison between buffer-treated cells and cells treated with HcpA, HcpC and PMA are 1.9  10-5, 0.10, and 1.2  104, respectively. Cells with star-
like morphologies were counted at six representative surface areas (0.64 mm2 each).
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cells were visually indistinguishable from buffer-treated cells.
Scanning electron microscopy was used to investigate these ef-
fects at higher resolution. After treatment with HcpA, ﬂow-through
buffer and PMA, Thp1 cells that adhered to glass cover slides were
ﬁxed with glutaraldehyde and osmium tetroxide and covered with
gold. These images revealed that HcpA treated Thp1 cells develop
approximately 20 needle-like protrusions (ﬁlopodia) per cell,
which correspond to the star-like morphology seen by phase-con-
trast light microscopy. These protrusions were 10–20 lm long and
had a typical width of less than 1 lm (Fig. 2a). In contrast to this,
buffer treated Thp1 cells were round shaped (8–12 lm diameter)
with almost no protrusions (Fig. 2b), whereas treatment with
PMA caused Thp1 cells to develop leaf-like protrusions (lamelopo-
dia) that tightly interacted with the glass cover slide (Fig. 2c), and
were distinct from the protrusions induced by HcpA.
3.2. Adherence
In untreated Thp1 and U937 cell cultures the majority of cells
ﬂoat freely in the medium. Treatment with HcpA stimulates the
development of ﬁlopodia that enable the cells to attach to the bot-
tom of the culture dishes. To quantify this effect, adherent cells and
cells in suspension were counted after stimulation with varying
concentrations of HcpA. Depending on the age of the cell culture
and the surface coating of the culture dish between 0.1% and 20%
of cells are loosely attached to the plastic surface even in the ab-
sence of stimulating agents, such as HcpA or PMA. Typically the
amount of loosely attached cells increases with the age of the cell
culture. Addition of HcpA causes a dose-dependent increase in
Thp1 cell adherence. With young Thp1 cell cultures (less than 1%
of cells adhered) HcpA addition at a concentration of 400 nM
caused 36% of cells to adhere (Fig. 3a); with old Thp1 cell cultures(approximately 15% spontaneously adhered) HcpA addition caused
90% of cells to adhere (data not shown). Neither the ﬂow-through
buffer of the ﬁnal HcpA concentration step (Fig. 3a) nor HcpC that
was puriﬁed in the same way as HcpA stimulated adherence. Less
than 10% of Thp1 cells adhered in tests with HcpC, independent of
the concentration used (Fig. 3b).
Cell adherence started within 1 h after the addition of HcpA and
reached its maximum of 70% within 4–6 h. The high level of cell
adherence persisted for at least 24 h and cells continued to prolif-
erate with approximately one cell division per day (Fig. 3c).
Although U937 cells did not show HcpA-induced morphological
changes, their adherence was also stimulated by HcpA addition, al-
beit less dramatically (Fig. 3d): from 2% of cells (no HcpA) to more
than 10% (300 nM HcpA), with a large increase between 50 nM and
100 nM HcpA. An equal volume of ﬂow-through buffer had no ef-
fect on the adherence of U937 cells.
3.3. Phagocytosis
Morphological changes and the onset of cellular adherence are
hallmarks for the differentiation of monocytes into macrophages.
Further signs of this differentiation process are increased phagocy-
tosis of opsonized particles, due to the expression of Fc-receptors
and other surface markers. Therefore we investigated the uptake
of ﬂuorescent microspheres by Thp1 cells that were stimulated
with HcpA, PMA, or ﬂow-through buffer, using ﬂow-cytometry.
When ﬂow-through buffer was used for the stimulation
12.0 ± 1.2% of living Thp1 cells contained phagocytosed particles,
which is almost identical to the fraction of cells in a control where
no stimulus was added (10.5 ± 0.6%). One day after the stimulation
with 283 nM HcpA or 333 nM PMA the fractions of Thp1 cells with
phagocytosed particles had increased to 30.3 ± 1.7% and
37.2 ± 2.8%, respectively (Fig. 4a and Supplementary Fig. 2). These
Fig. 2. Scanning electron microscopy images of typical Thp1 cells 7 h after treatment with (a) 230 nM HcpA (1:10 000 magniﬁcation), (b) with an equal volume of ﬂow-
through buffer (1:21 000 magniﬁcation), and (c) with 230 nM PMA (1:6000 magniﬁcation).
0.0E+00
4.0E+05
8.0E+05
1.2E+06
1.6E+06
2.0E+06
1000100101
[HcpA] (nM)
N
o.
 o
f c
el
ls
 
0%
4%
8%
12%
16%
20%
ad
he
re
nt
   
fr
ac
tio
n 
0.0E+00
4.0E+05
8.0E+05
1.2E+06
1.6E+06
2.0E+06
0 5 10 15 20 25 30
time (h)
N
o.
 o
f c
el
ls
 
0%
20%
40%
60%
80%
100%
ad
he
re
nt
   
fr
ac
tio
n 
0.0E+00
2.0E+05
4.0E+05
6.0E+05
8.0E+05
1.0E+06
100010010
[HcpC] (nM)
N
o.
 o
f c
el
ls
 
0%
10%
20%
30%
40%
50%
ad
he
re
nt
   
fr
ac
tio
n 
0.0E+00
2.0E+05
4.0E+05
6.0E+05
8.0E+05
1.0E+06
0.1 1 10 100 1000
[HcpA] (nM)
N
o.
 o
f c
el
ls
 
0%
10%
20%
30%
40%
50%
ad
he
re
nt
   
fr
ac
tio
n 
a b
c d
Fig. 3. Adherence of cells after stimulation. Total number of cells (crosses), number of cells in suspension (open squares), number of adherent cells (open triangles), and
fraction of adherent cells (broken line). Adherent cells and cells in suspension after treatment with a corresponding volume of ﬂow-through buffer are indicated by ﬁlled
squares and triangles, respectively. (a) Dose–response curve for the stimulation of Thp1 cells with HcpA. (b) Dose–response curve for the stimulation of Thp1 cells with HcpC.
(c) Time-course for Thp1 cell adherence after stimulation with 123 nM HcpA. (d) Dose–response curve for the stimulation of U937 cells with HcpA.
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the ability of Thp1 cells to phagocytose opsonized microspheres.
3.4. Molecular surface markers
The expression of speciﬁc molecular markers, such as the b2
integrin CD11b, is indicative of the maturation of monocytes into
macrophages. Twenty-four hours after stimulation the expression
of CD11b was quantiﬁed by ﬂow-cytometry. Thp1 cells that weretreated with either 340 nM HcpA or 250 nM PMA revealed average
ﬂuorescence intensities of 164 ± 0.6 ﬂuorescence units (FU) and
163 ± 1.2 FU, respectively. In contrast, ﬂow-through buffer treated
cells showed an average ﬂuorescence intensity of 154 ± 1.0 FU,
which is identical to the background intensity of 155 ± 0.7 FU
(Fig. 4b). Thp1 cells that were stimulated with 240 nM HcpC did
not show an elevated expression of CD11b (Supplementary
Fig. 3). Thus, HcpA, like PMA, caused up-regulation of CD11b
expression, whereas buffer- or HcpC treatment had no effect.
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Fig. 4. Flow-cytometry analysis of Thp1 cells. (a) Fraction of cells with phagocy-
tosed ﬂuorescent microspheres. P-values for the stimulation with HcpA and PMA
are 2.6  103 and 1.0  103, respectively. (b) Mean ﬂuorescence intensity of cells
stained with a ﬂuorescent anti-CD11b antibody. P-values for the stimulation with
HcpA and PMA are 4.1  104 and 5.0  104, respectively.
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To correlate the in vitro data with the colonization behaviour of
H. pylori, an hcpA knockout derivative of strain X47 was in parallel
with isogenic X47 wild-type tested by oral gavage of C57BL/6 mice
(n = 3). Colonization was estimated by culture of gastric mucosa
from mice sacriﬁced 2 weeks after inoculation. The hcpA knockout
mutant colonized the stomachs of each of several mice tested at
approximately the same level as the isogenic X47 wild-type parent.
This showed that hcpA is not essential for H. pylori in vivo.
4. Discussion
Here we show that the immunogenic H. pylori protein HcpA has
an effect like that of the tumor promoter PMA on the differentia-
tion of Thp1 monocytes. HcpA causes the development of ﬁlopodia
and adherence within a few hours of addition to cell cultures, in-
duces the ability to phagocytose opsonized microspheres, and
causes elevated expression of the macrophage marker CD11b.
These results agree with and extend an earlier report that HcpA in-
duces the release of cytokines, such as INF-c, TNF-a, IL-6, IL-10,
and IL-12 in a cellular assay of naïve mouse splenocytes [15].
Therefore we conclude that HcpA induces the differentiation of
freely circulating monocytes into sessile macrophages. Although
HcpA and -C share 56% sequence identity HcpC does not exert such
effects (Supplementary Fig. 4), and thus it likely has other roles
during H. pylori infection. The intensity of the HcpA-induced differ-
entiation is cell line dependent. Thp1 and U937 cells each belong to
the mononuclear phagocyte lineage, but HcpA has a much stronger
effect on Thp1 cells than on U937 cells. We suggest this is becauseU937 cells are promonocytic cells that are less differentiated than
Thp1 cells [22].
Both cell lines are sensitive to contamination with living bacte-
ria and bacteria derived endotoxins. Control experiments with
ﬂow-through buffers and with HcpC ruled out contamination-
based explanations for our results. In addition, endotoxin concen-
trations of protein preparations and ﬂow-through buffers, deter-
mined by the extremely sensitive Limulus amebocyte lysate test,
were found to be extremely low (<1.25 EU/ml), and proteolytic
digestion with Pronase and subsequent heat denaturation abro-
gated the ability of HcpA preparations to induce the star-like phe-
notype and adherence (data not shown). We conclude that Thp1
differentiation is induced by a temperature and protease sensitive
macromolecule, most likely HcpA.
To test for possible HcpA essentiality in vivo, we compared col-
onization densities of an hcpA deletion knockout mutant strain and
its isogenic wild-type parent in a 2-week C57BL/6 mouse infection
model. No difference in was observed. This result shows that HcpA
is not essential during the critical establishment phase of infection.
Whether it shares overlapping functions with other H. pylori-en-
coded immune modulators, and how it might affect bacterial per-
sistence and host responses during long term mouse infection, or
in models with more severe pathologic effects (e.g., Mongolian ger-
bils or speciﬁc types of mutant mice) merit testing in the future.
Our results are consistent with a previous report on the hcpA
knockout H. pylori strain 2802, which displayed a similar cytokine
proﬁle like the wild-type when used to challenge splenic cells of
naïve BALB/c mice [15].
Why should H. pylori foster monocyte maturation? Monocytes
are the precursors for macrophages and dendritic cells and both
cell types are crucial for triggering the innate immune response
and combating infection. Although the inﬂux of myeloid dendritic
cells (CD11b positive) into the lamina propria of the gastric mucosa
in response to H. pylori infection is well known [23], the possibility
of H. pylori susceptibility to phagocytosis is controversial. Invading
macrophages have seemed to be dysfunctional, and H. pylori re-
sisted phagocytosis in one study [24], whereas H. pylori stimulated
its own uptake into speciﬁc vacuoles called megasomes through
transient activation of the protein kinase-C (PKC) isoenzymes f in
another study [25].
If stimulating monocyte to macrophage differentiation does
not help clear H. pylori infection, we propose that it could actu-
ally promote H. pylori infection of the gastric mucosa by any of
several means: (i) the strong immune response causes mamma-
lian cell lysis and liberation of nutrients upon which H. pylori
may feed. (ii) Activating the maturation of monocytes could
eliminate microorganisms that would compete with H. pylori in
its gastric niche, but that are less resistant against macrophage
attack [26]. This could be especially important after H. pylori-
elicited suppression of gastric acidity. Finally (iii) HcpA could
penetrate deeply into host tissue, due to its extraordinary stabil-
ity, where it could arrest circulating monocytes before they enter
the site of infection. In this case host immune cells would be dis-
tracted from their normal function to attack the invading
microorganism.
The details of the HcpA signalling pathway remain to be exam-
ined. One possibility might be that HcpA serves as a pathogen-
associated molecular pattern (PAMP). The HcpA homologue
Hsp12 is up-regulated under iron-, pH- and temperature-stress
conditions [27]. Thus, Hsp12 and HcpA are regarded as heat-shock
proteins, which often serve as PAMPs (reviewed in [28]). Eukary-
otic cells sense bacterial PAMPs, such as bacterial lipoproteins,
LPS, and ﬂagellin, by means of membrane-bound and cytoplasmic
pattern recognition receptors (PRR) such as the Toll-like receptors
(TLR), the best-studied members of the PRR family. However, H. py-
lori LPS and ﬂagellin are virtually inactive in binding to human
1642 C. Dumrese et al. / FEBS Letters 583 (2009) 1637–1643TLRs; this illustrates one of H. pylori’s adaptations for evasion of the
innate immune response [29,30].
On the other hand, TLRs are weakly expressed in Thp1 mono-
cytes and PMA-treatment is generally used as an in vitro tool to
trigger TLR up-regulation and to prime Thp1 cells for PAMP recog-
nition [31]. Therefore un-stimulated Thp1 monocytes are rather
insensitive to PAMPs, such as LPS. Considering the low TLR expres-
sion level in un-stimulated Thp1 cells, it remains questionable
whether HcpA acts through a PRR-dependent pathway. However,
HcpA could still act through an autocrine feedback loop, involving
the recognition of HcpA by a weakly expressed PRR and subse-
quent release of cytokines that trigger the morphological changes
described above.
Other signalling pathways should also be considered. The
observation that HcpA, like cancer-promoting agent PMA, elicits
adherence and differentiation within a few hours of administration
suggests that they might function by similar mechanisms. PMA in-
duces differentiation and TNF-a release from monocytes by the
activation and subsequent translocation of PKC isoenzymes (re-
viewed in [32,33]). Other SLR proteins such as ExoR from Sinorhizo-
bium melioti, PodJ from Caulobacter crescentus, Nif1 from
Schizosaccharomyces pombe, and Ack1 form Saccharomyces cerevisi-
ae recognize the endogenous protein kinases ExoS, PleC, Nim1, and
PKC1 respectively [34–37]. The functional analogy between HcpA
and PMA and the structural homology between HcpA and other
SLR proteins suggest that HcpA could transmit a signal for mono-
cyte maturation through activation of a yet unidentiﬁed protein
kinase.
We conclude that in vitro HcpA shows molecular and functional
hallmarks of a bacterial immune modulator similar to a eukaryotic
cytokine. HcpA is secreted by H. pylori cells and folds into a stable
three-dimensional structure, consisting of six disulﬁde-bridged
SLRs (Supplementary Fig. 4) [12,17]. Its close homologue HcpC
does not show any of these effects and the functional properties
of the other HcpA orthologues in H. pylori genomes are unknown.
It is tempting to speculate that they might have similar or comple-
mentary molecular functions, and altogether constitute a well bal-
anced molecular toolbox that enables H. pylori to ﬁne-tune
eukaryotic signalling mechanisms according to its own needs. Clo-
sely related HcpA homologues have been identiﬁed in the genome
sequences of other pathogens and symbionts from the Helicobacter,
Campylobacter, Wolinella, and Arcobacter lineages, suggesting that
these microorganisms possess similar capacities for managing
eukaryotic immune responses.
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